Cover Image

Cost-effectiveness of dostarlimab plus chemotherapy for primary advanced or recurrent endometrial cancer

ObjectiveIn the double-blind, phase III, placebo-controlled RUBY randomized clinical trial, dostarlimab plus carboplatin-paclitaxel significantly increased survival among patients with primary advanced or recurrent endometrial cancer (EC). We conducted a cost-effectiveness analysis of dostarlimab in...

Full description

Saved in:

Bibliographic Details
Main Authors:	Gengwei Huo (Author), Ying Song (Author), Wei Liu (Author), Hua Guo (Author), Peng Chen (Author)
Format:	Book
Published:	Frontiers Media S.A., 2024-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Toripalimab plus chemotherapy vs. chemotherapy in patients with advanced non-small-cell lung cancer: A cost-effectiveness analysis
by: Gengwei Huo, et al.
Published: (2023)

First-line tremelimumab plus durvalumab and chemotherapy versus chemotherapy alone for metastatic non-small cell lung cancer: a cost-effectiveness analysis in the United States
by: Wenjie Liu, et al.
Published: (2023)

Cost-effectiveness of first-line versus second-line use of brigatinib followed by lorlatinib in patients with ALK-positive non-small cell lung cancer
by: Wenjie Liu, et al.
Published: (2024)

Osimertinib in the treatment of resected EGFR-mutated non-small cell lung cancer: a cost-effectiveness analysis in the United States
by: Gengwei Huo, et al.
Published: (2024)

Working Situation and Research Willingness: A Case of Primary School Teachers in The Southeast of China
by: Huo-Hua Gan
Published: (2022)

Secular Trends in Gastric and Esophageal Cancer Attributable to Dietary Carcinogens From 1990 to 2019 and Projections Until 2044 in China: Population-Based Study
by: Hui-Xiao Guo, et al.
Published: (2023)

Safety and efficacy of immune checkpoint inhibitors in advanced cancer patients with autoimmune disease: A meta-analysis
by: Qi Cai, et al.
Published: (2022)

Lenvatinib Plus Pembrolizumab vs. Chemotherapy in Pretreated Patients With Advanced Endometrial Cancer: A Cost-Effectiveness Analysis
by: Mingyang Feng, et al.
Published: (2022)

Time Series Analysis in Modeling of Hepatitis B Incidence
by: Hua ZHANG, et al.
Published: (2019)

Willing to Pay for Antiviral Treatment of Hepa¬titis B Patients
by: Hua ZHANG, et al.
Published: (2016)

Physical Therapy Modalities of Western Medicine and Traditional Chinese Medicine for Meibomian Gland Dysfunction
by: Li Jie, et al.
Published: (2020)

Nervonic acid as novel therapeutics initiates both neurogenesis and angiogenesis for comprehensive wound repair and healing
by: Yu-Da Liu, et al.
Published: (2024)

Antiretroviral Long-Term Efficacy and Resistance of Lopinavir/Ritonavir Plus Lamivudine in HIV-1-Infected Treatment-Naïve Patients (ALTERLL): 144-Week Results of a Randomized, Open-Label, Non-Inferiority Study From Guangdong, China
by: Peng-Le Guo, et al.
Published: (2021)

The integration of urban and rural medical insurance to reduce the rural medical burden in China: a case study of a county in Baoji City
by: Pei Liu, et al.
Published: (2018)

Successful neoadjuvant chemotherapy plus sintilimab for locally advanced cervical cancer: case series and review of the literature
by: Linlin Liu, et al.
Published: (2023)

Comparison between clinical features and prognosis of malignancy- and non-malignancy-associated pediatric hemophagocytic lymphohistiocytosis
by: Hua Pan, et al.
Published: (2019)

Cost-Effectiveness of Pembrolizumab Plus Chemotherapy as First-Line Therapy for Advanced Oesophageal Cancer
by: Meiyu Wu, et al.
Published: (2022)

Population pharmacokinetic study of pemetrexed in chinese primary advanced non-small cell lung carcinoma patients
by: Peng Cao, et al.
Published: (2022)

Retroperitoneal kaposiform hemangioendothelioma with kasabach-merritt phenomenon in children: A case report and review of the literature
by: Junming Huo, et al.
Published: (2023)

Evaluation of Drug-Related Receptors in Children With Dilated Cardiomyopathy
by: Qing Guo, et al.
Published: (2019)

The impact of the COVID-19 pandemic on firms: a survey in Guangdong Province, China
by: Peng Zou, et al.
Published: (2020)

A NIR-Activated and Mild-Temperature-Sensitive Nanoplatform with an HSP90 Inhibitor for Combinatory Chemotherapy and Mild Photothermal Therapy in Cancel Cells
by: Yingying Peng, et al.
Published: (2023)

Cost-effectiveness analysis of lenvatinib plus pembrolizumab compared with chemotherapy for patients with previously treated mismatch repair proficient advanced endometrial cancer in China
by: Zhiwei Zheng, et al.
Published: (2022)

Atezolizumab Plus Chemotherapy vs. Chemotherapy in Advanced or Metastatic Triple-Negative Breast Cancer: A Cost-Effectiveness Analysis
by: Xiaoyan Liu, et al.
Published: (2021)

Hotspots and Frontiers in Inflammatory Tumor Microenvironment Research: A Scientometric and Visualization Analysis
by: Yuli Zhang, et al.
Published: (2022)

Efficacy of extracellular vesicles as a cell-free therapy in colitis: a systematic review and meta-analysis of animal studies
by: Jun-Jie Hou, et al.
Published: (2023)

Benidipine Hydrochloride Inhibits NLRP3 Inflammasome Activation by Inhibiting LPS-Induced NF-κB Signaling in THP-1 Macrophages
by: Huo M, et al.
Published: (2024)

Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab for Advanced Non-Small-Cell Lung Cancer
by: Xiaomin Wan, et al.
Published: (2021)

Chemotherapy-Induced Peripheral Neurotoxicity and Complementary and Alternative Medicines: Progress and Perspective
by: Xiao-Lan eCheng, et al.
Published: (2015)

Combined inhibition of PARP and EZH2 for cancer treatment: Current status, opportunities, and challenges
by: Xi Zhang, et al.
Published: (2022)

Treatment of Stretch Marks Using a New Formulation Combining Nanofractional Radiofrequency Plus Magnetic Nanofractional Radiofrequency
by: Xiaohong Shu, et al.
Published: (2023)

Sugemalimab plus chemotherapy vs. chemotherapy for metastatic non-small-cell lung cancer: A cost-effectiveness analysis
by: Xueyan Liang, et al.
Published: (2023)

Case Report: Novel TRPM6 Mutations Cause Hereditary Hypomagnesemia With Secondary Hypocalcemia in a Chinese Family and a Literature Review
by: Yiran Han, et al.
Published: (2022)

Behavioral decision-making of government, agricultural product producers, and consumers on agricultural product quality and safety regulation in a digital environment
by: Hong Huo, et al.
Published: (2024)

Tocilizumab treatment for COVID-19 patients: a systematic review and meta-analysis
by: Qiu Wei, et al.
Published: (2021)

Cost-Effectiveness of Avelumab Maintenance Therapy Plus Best Supportive Care vs. Best Supportive Care Alone for Advanced or Metastatic Urothelial Carcinoma
by: Qian Xie, et al.
Published: (2022)

Emerging role of antidiabetic drugs in cardiorenal protection
by: Wen-Jia Fu, et al.
Published: (2024)

Intracranial Metastases Tend to Be Overt and Predict Poor Prognosis in Children With Neuroblastoma
by: Ying Liu, et al.
Published: (2021)

Predictors of quitting support from nonsmoking mothers for smoking fathers: a cross-sectional study from Chinese pupils' families
by: Nan Jiang, et al.
Published: (2024)

Pharmacology of Dostarlimab: A Review
by: Arnab Roy, et al.
Published: (2022)